Evaluation of Serum Soluble CD36 Levels in the Clinical Progression of Diabetic Nephropathy.

Increased serum sCD36 levels correlates directly to DN progression, hence being a promising candidate biomarker for diagnosis and prognosis. The possible direct application of sCD36 into clinical practice might help improve DN management and treatment.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2025-12-01
Primary Topic
Peroxisome Proliferator-Activated Receptors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of Serum Soluble CD36 Levels in the Clinical Progression of Diabetic Nephropathy.

Eswara Karthick, Iyyama Gowri Moovendhan, K Sowmya, A K Roopa et al.
PubMed
Peroxisome Proliferator-Activated Receptors
article

Evaluation of Serum Soluble CD36 Levels in the Clinical Progression of Diabetic Nephropathy.

Eswara Karthick, Iyyama Gowri Moovendhan, K Sowmya, A K Roopa, M Ganesh
article en

Abstract

Increased serum sCD36 levels correlates directly to DN progression, hence being a promising candidate biomarker for diagnosis and prognosis. The possible direct application of sCD36 into clinical practice might help improve DN management and treatment.

PubMedVol. 36(4)
SRM Institute of Science and Technology (IN), Sri Ramachandra Institute of Higher Education and Research (IN), Sri Ramachandra Medical Centre (IN)
Good health and well-being
Openalex Percentile: Top 35%
Peroxisome Proliferator-Activated Receptors
OpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Evaluation of Serum Soluble CD36 Levels in the Clinical Progression of Diabetic Nephropathy. — Eswara Karthick, Iyyama Gowri Moovendhan, et al. · PubMed (2025) | TGRS Research Map | TGRS